Physician profile
Matthew Steffes
NPI 1720472061
$67,204.67
in general payments reported to CMS, 2019-2025
17 companies · $2,876 in 2025
The $2,876 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,157 · 2020: $33K · 2021: $20K · 2022: $4,802 · 2023: $2,553 · 2024: $2,716 · 2025: $2,876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,273 · Food and Beverage: $2,623 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,272.71 |
| Food and Beverage | $2,622.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $29,192.54 | 2020-2025 | |
| Micromed INC | $17,735.87 | 2020-2021 | |
| Elite Orthopedics, LLC | $9,265.73 | 2021-2025 | |
| Smith+Nephew, INC. | $5,392.03 | 2019-2021 | |
| Stryker Corporation | $4,770.90 | 2019-2025 | Blueprint Patient Specific Instrumentation, Motionsense Digital Goniometer, Insignia |
| Zimmer Biomet Holdings, INC. | $294.05 | 2019-2021 | |
| Pacira Therapeutics, INC. | $271.51 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $87.76 | 2024-2025 | |
| Ermi LLC | $33.83 | 2024 | |
| Ethicon US, LLC | $33.67 | 2024 | Dermabond Prineo |
| Kci USA, INC. | $27.00 | 2021 | |
| Depuy Synthes Sales INC. | $24.04 | 2025 | Actis |
| Fidia Pharma USA INC. | $18.73 | 2023 | Hymovis, Triluron |
| Solventum Corporation | $16.56 | 2024 | V.A.C.Instill, Prevena |
| Ferring Pharmaceuticals INC. | $14.56 | 2024 | Euflexxa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $13.78 | 2023 | Celleraterx |
| Vericel Corporation | $12.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Steffes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.